Trending
October 1, 2024

Luxa Biotechnology Appoints Keith E. Dionne, Ph.D., as Chief Executive Officer

October 1, 2024

Merck Completes Acquisition of Investigational B-Cell Depletion Therapy, CN201, from Curon Biopharmaceutical

October 1, 2024

T. Rowe Price Funds Join $175M Series B for Aktis Oncology

September 30, 2024

NRx Pharmaceuticals Announces Completion of Twelve Months of Stability on the First Manufactured Commercial Scale Lot of NRX-100 (Ketamine)

September 30, 2024

Aktis Oncology Announces $175M Series B Financing

September 26, 2024

Century Therapeutics Appoint Morgan Conn, Ph.D., as CFO and Chad Cowan, Ph.D., as CSO

September 25, 2024

Sonnet BioTherapeutics Announces 1-for-8 Reverse Stock Split

September 24, 2024

PCI Pharma Services Invests Over $365 Million in EU

September 23, 2024

Maternal Health Startup Canopie Raises $3.7 Million

September 20, 2024

NRx Pharmaceuticals Featured on Psychiatrist.com

September 20, 2024

Traws Pharma Appoints Luba Greenwood to Board of Directors

September 19, 2024

D.A. Davidson Acts as Exclusive Financial Advisor to Turnspire Capital Partners for Debt Financing in Support of Turnspire’s Acquisition of Pharmachem

September 18, 2024

Main Line Health CEO Jack Lynch to Retire

September 18, 2024

Lighthouse Life Acquires Key Assets of Settlement Benefits Association

September 17, 2024

Tris Pharma Promotes Manesh Naidu to Chief Commercial Officer

September 16, 2024

Quest Diagnostics Completes Acquisition of Select Lab Assets from Allina Health